Rapid Nutrition Unveils Robust Financial Performance for 2023 and Strategic Roadmap for 2024
London, United Kingdom – 12 February 2024 - Rapid Nutrition PLC (Euronext Growth: ALRPD) an established natural healthcare enterprise committed to advancing top-tier health and wellness brands globally, is pleased to announce its exceptional fiscal achievements for the year 2023, along with its strategic objectives for the ensuing year. Rooted in a resolute commitment to providing scientifically-driven products crafted "by nature, refined by science," Rapid Nutrition continues to foster innovation and fortify its market footprint on a global scale.
Key Financial Highlights of 2023
Ahead of final audited results for the fiscal year 2023, Rapid Nutrition attained significant financial milestones, epitomizing resilience and strategic advancement through the meticulous execution of its Direct-to-Consumer channels, propelling online revenue growth. Despite prevailing market adversities, the company anticipates maintaining a robust gross profit margin in FY2023, underscoring its unwavering dedication to operational excellence. Furthermore, the company's liabilities are poised to have witnessed a remarkable reduction of approximately 83% compared to the preceding year, while its Cash Position is projected to have surged by approximately 107%, positioning the company favourably for sustained growth and financial solidity in the forthcoming fiscal period.
Strategic Vision for 2024
Embarking on the trajectory into 2024, Rapid Nutrition remains steadfast in its pursuit of catalysing growth and fostering innovation across pivotal facets of its operations:
1. Market Expansion: Rapid Nutrition endeavours to amplify its distribution footprint into adjacent markets, with a strategic focus on penetrating the UK, Europe, China, Australia, and the United States. By leveraging its premium brands and deploying high-quality ingredients, the company endeavours to seize market prospects and fortify its global presence.
2. Product Innovation: Building upon the success of its flagship brand, SystemLS, Personalized Nutrition, and Azurene, Rapid Nutrition is committed to perpetuating innovation and broadening its product portfolio to create additional revenue streams. With an emphasis on plant-based vegan formulations and the integration of novel patented treatments such as Azurene, the company is well positioned to cater to the evolving consumer preferences in the realm of health and wellness.
3. Corporate Social Responsibility: Rapid Nutrition remains unwavering in its pledge to curbing its carbon footprint and propelling its corporate social responsibility endeavours. Through prioritising sustainable practices and fostering transparency in ingredient sourcing, the company endeavours to effectuate a positive environmental and societal impact within the communities it serves.
Strategic Initiatives Paving the Way for 2024
Following the shareholder-approved share reconsolidation in January, the Company's comprehensive business transformation initiative is well underway. The Company anticipates unveiling a significant update to the market imminently, marking a significant milestone for its flagship brand.
Management has outlined to support this pivotal program, management has also partnered with a global logistics partner, in addition to engaging with one of Australia's preeminent marketing agencies to expedite the company's 'direct-to-consumer' channel of the back of this program to be announced in the coming days. Additionally, these initiatives are poised to realign Rapid's operations toward a more efficient cost structure, fostering enhanced scalability and facilitating sustained growth.
According to Research and Markets, "The Weight Loss Products and Services Market Forecast continues to Soar; Asia-Pacific Region to Witness Rapid Growth," further validating the Company's strategic investment in venturing into the APAC region, with an initial focal point on China.
Optimistic Outlook and Future Prospects
In light of recent developments, prevailing market trends, and ongoing product innovation endeavours bolstered by strategic partnerships, Rapid Nutrition remains optimistic about its prospects for the future. The amalgamation of these strategic imperatives is poised to underpin a meticulous reassessment of the company's operations, ensuring the cultivation of a sustainable, efficiently-operating business model, while simultaneously fostering a growth-oriented mindset to capitalise on emergent opportunities.
Commentary from Management
Simon St Ledger, Executive Chairman of Rapid Nutrition, shared his insights regarding the company's accomplishments and outlook for 2024:
"In 2023, Rapid Nutrition charted significant milestones in expanding its market outreach, driving product innovation, and fortifying its financial standing. As we chart our course for 2024, we remain steadfast in executing our growth strategy and delivering value to our esteemed customers, shareholders, and partners.”
For more information and to stay informed about the official product launch, please visit http://rnplc.com
About Rapid Nutrition
Rapid Nutrition is a leading health and wellness company committed to providing innovative solutions for a healthier world. With a focus on research-backed formulas, we empower individuals to optimize their well-being and face life's challenges with confidence.
Investor Relations Contact:
Disclaimer
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and or otherwise that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid Nutrition PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.
This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 of June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71 or a listing prospectus within the meaning of the listing rules of the Euronext Exchange or OTC Markets. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).